Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, and idempotentHint, so the bar is lower. The description adds rich behavioral context: it discloses internal cascading lookups ('replaces 2-3 manual lookups'), graceful degradation when GLEIF/OpenFIGI are unavailable, explicit listing of unresolved identifiers, and the behavior of returning figi_candidates when ambiguity exists. It also explains that non-equity instruments (bonds) are covered, which is non-obvious. This goes well beyond what annotations provide.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but well-structured: it leads with a purpose statement and directive, then enumerates supported types, then details edge cases and fallbacks. It uses quotes and examples to break up text. While it could be trimmed, the density of critical information (e.g., bond issuer name handling, unresolved identifiers) justifies the length. It's not bloated or repetitive.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with two entity types and multiple identifier sources, the description covers every aspect an agent needs: input format, output expectations (including unresolved and candidates), failure modes, and even performance characteristics ('replaces 2-3 manual lookups'). There is no output schema, so the description carries the burden of describing return behavior, and it does so comprehensively.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% (both parameters described). The description adds substantial nuance: for 'value', it explains exactly what to pass for company (ticker, CIK, or name) vs drug (brand or generic), and warns against including trailing security-class words for bonds. For 'type', it clarifies the meaning of each enum value and what identifiers are returned. The description complements the schema rather than repeating it.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete example queries and states clearly: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It enumerates the exact identifier set (CIK, ticker, LEI, FIGI, RxCUI) and supported types (company, drug). The phrase 'Use FIRST whenever you have a name but need an ID' explicitly distinguishes it from sibling tools like entity_profile or compare_entities, making the purpose unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives a clear directive: 'Use FIRST whenever you have a name but need an ID.' It also explains when to avoid using it (e.g., when a name matches multiple instruments, it returns candidates rather than asserting). It provides detailed input instructions for each entity type, including a warning for bonds to pass only the issuer name, not the full noun phrase. This is explicit, actionable usage guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all perform overlapping routed-search functions; ask_pipeworx_beta is even documented as currently identical to ask_pipeworx. The three Polymarket discovery tools (polymarket_edges, polymarket_arbitrage, polymarket_fill_risk) also have blurry boundaries around finding vs. validating vs. executing on edges.

Naming Consistency4/5

Nearly all tools use snake_case with a verb_noun or descriptive pattern (ask_pipeworx, validate_claim, resolve_entity, list_subscriptions). Minor deviations exist — bare verbs like remember/recall/forget and noun_first names like bet_research or entity_profile — but the convention is largely predictable and readable.

Tool Count2/5

32 tools is heavy, and the set spans unrelated domains: Pipeworx data routing, prediction-market trading, agent memory, subscription management, npm dependency checks, user-agent parsing, and llms.txt generation. The sub-clusters each earn their place individually, but as a single server surface the count is unjustifiably large and scattershot.

Completeness3/5

The Pipeworx research surface is quite complete (lookup, grounded answers, deep research, entity profiles, comparisons, validation, entity resolution, discovery, feedback), and memory/subscription lifecycles are fully covered. However, the server has no coherent single domain — user-agent parsing (the server's namesake) has only one tool, while unrelated utilities like generate_llms_txt and scan_dependency appear with no supporting ecosystem.